Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
7 Cards in this Set
- Front
- Back
describe azathioprine & mercaptopurine
|
thiopurine immunomodulatory (potent antiinflammatory) drugs (azathioprine is converted to mercaptopurine). both inhibit purine synthesis & gene replication in rapidly dividing cells
|
|
what are the possible side effects of azathioprine & mercaptopurine?
|
1. macrocytosis & lymphopenia (don't need to stop therapy)
2. nausea, vomiting, diarrhoea, fever, headache, malaise, rash, myalgia, joint pain - can mimic exacerbation of illness 3. impaired liver function, renal function, pancreatitis, bone marrow toxicity, hair loss, skin cancers |
|
why should allupurinol be avoided in patients taking azathioprine or mercaptopurine?
|
allupurinol inhibits xanthine oxidase, which metabolises azathioprine/mercaptopurine
|
|
what monitoring is needed for patients taking azathioprine or mercaptopurine
|
LFTs
FBCs (lymphopenia, bone marrow suppression) |
|
cyclosporin mechanism of action
|
inhibits cytokine release from activated T cells
|
|
adverse effects of cyclosporin
|
most common: reversible renal impairment, hypertension
others: hirsutism, gum hypertrophy, hepatic dysfunction, burning hands & feet, pancreatitis, hyperlipidaemia, oedema, weight gain, haematological disturbances, CNS disturbance (headache, tremor), hyperkalaemia, hypermagnaesemia, hyperuricaemia, increased rate of malignancies |
|
what monitoring is needed for cyclosporin?
|
baseline FBC, LFT, EUC, fasting lipids, BP
Annual skin check |